Why COVID-19 Vaccines Are Difficult to Manufacture and Improve Care
With demand for COVID-19 A frustrated public and policy makers want to know: How can we do more? A lot more. Right now.
The problem: “It’s not like adding more water to the soup,” said vaccine specialist Maria Elena Bottazzi of Baylor College of Medicine.
COVID-19 vaccine makers need everything to grow production to hundreds of millions of doses – and any small hiccups can cause delays. Some of their ingredients have never been made in the quantities needed.
And seemingly simple suggestions that other factories are brewing new types of vaccines cannot come overnight. Just this week, the French drug maker Sanofi …